Диссертация (1139891), страница 13
Текст из файла (страница 13)
- 2013. - 32(3). - 511-22.83.Liu T., Mu H., Shen Z., Song Z., Chen X., Wang Y. Autologousadipose tissue-derived mesenchymal stem cells are involved in rat liverregeneration following repeat partial hepatectomy //Mol Med Rep.-2016.-13(3).-2053–59.84.Liu W., Song F., Ren L.N., Guo W.Q., Wang T., Frenq L.J., TangL.J, Li K. The multiple functional roles of mesenchymal stemcells inparticipating in treating liver diseases // Cell. Mol. Med.-2015.-3.-511-20.85.Liu Z.C., Chang T.M. Research Article Intrasplenic Transplantationof Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of90% Partial Hepatatecromized Rats // Hindawi Publishing Corporation StemCells International.-2012.- 1-6.86.Lu H., Lu L., Zhang F., Zhai Y., Wang X.
Living donor livertransplantation: where do we stand and where are we going? // HepatobiliarySurg Nutr. - 2016. - 5(2). - 141-4.87.Lysy P.A., Smets F., Sibille C., Najimi M., Sokal E.M. Human skinfibroblasts from mesoderms to hepotocyte-like differentiation // Hepatology.2007.-46.-1574-75.88.Ma H.C., Shi X.L., Ren H.Z., Yuan X.W., Ding Y.T. Targetedmigration of mesenchymal stem, cells modified with CXCR4 to acute failingliver improves liver regeneration // World J Gastroenterol.-2014.-14884-94.89.Maeda M., Takami T., Terai S., Sakaida I.
Autologous bonemarrow cell infusions suppress tumor initiation in hepatocarcinogenic mice withliver cirrhosis // J Gastroenterol Hepatol.-2011.-27.-104-11.10190.Maes M., Vinken M., Jaeschke H. Experimental models ofhepatotoxicity related to acute liver failure // Toxicol Appl Pharmacol.2016.-1.-290.-86-97.91.MahnkenA.H.Currentstatusoftransarterialradioembolization // World J Radiol. - 2016.
- 8(5). 449–459.92.Margeli A.P., Papadimitriou L., Ninos S., Manolis E.,Myconiatis M.G., Theocharis S.E. Hepatic stimulator substanceadministration ameliorates liver regeneration in an animal model offulminant hepatic failure and encephalopathy // Liver International.-2003.23.-171-8.93.Martins P.N., Theruvath T.P., Neuhaus P. Rodent models ofpartial hepatectomies // Liver Int.-2008.-28.-3-11.94.Masahiro M., Marhsen H., Takuro M., Kojl T., Naila M.,Reinhold J.
M., Aya N., Hiroyuki S., Gang D., Rong Y., Mikiro T.,Masakiyo S., Nam-Ho H. Isolation of a Bone Marrow-Derived Stem CellLine with High Proliferation Potential and Its Application for PreventingAcute Fatal Liver Failure // STEM CELLS. - 2007.
- 25/ - 2855–63.95.Masson S., Harrison D.J., Plevris J.M. Potential ofhematopoietic stem cells therapy in hepatology: a critical review // StemCells.-2004-22.-897-907.96.Matsuda M., Kato K., Mito M. [Effect of RES on liverregeneration and survival after 90% partial hepatectomy] // Nihon GekaGakkai Zasshi.-1994.-95(9).-662-8.97.Michalopoulos G K. Liver regeneration after partialhepatectomy: critical analysis of mechanistic dilemmas // Am J Pathol. 2010. - 176(1). - 2-13.10298.Michalopoulos G.K., Barua L., Bowen W.C.
Transdifferentiation ofrat hepatocyte into biliary cells after bile duct ligation and toxic biliary injury //Hepatology.-2005.-41.-535-44.99.Michalopoulos G.K., Bowen W.C., Mulè K., Lopez-Talavera J.C.,Mars W. Hepatocytes undergo phenotypic transformation to biliary epitheliumin organoid cultures // Hepatology.-2002.-36.-278–83.100. Michalopoulos G.K., DeFrances M. Liver regeneration // Adv.Biochem. Eng. Biotechnol.
- 2005. - 93. - 101–34.101. Michalopoulos G.K., Grompe M., Theise N.D. Assessing thepotential of induced liver regeneration // Nat. Med. - 2013. - 19(9). - 1096-7.102. Michalopoulos K G. Liver regeneration // Science. - 1997. - 276. 60.103. Minato M., Houssin D., Demma I., Morin J., Gigou M., SzekelyA.M., Bismuth H. Transplantation of hepatocytes for treatment of surgicallyinduced acute hepatic failure in the rat // Europ. surg.-1984.-16.-162-9.104. Mito M., Kusano M. Hepatocyte transplantation in man // CellTransplant.-1993.-2.-65–74.105. Mitry R.R., Dhawan A., Hughes R.D., Bansal S., Lehec S., TerryC., Heaton N.D., Karani J.B., Mieli-Vergani G., Rela M. One liver, threerecipients: segment IV from split-liver procedures as a source of hepatocytes forcell transplantation // Transplantation.-2004.-77.-1614–16.106.
Miyazaki M., Hardjo M., Masaka T., Tomiyama K., Mahmut N.,Medina R.J., Niida A., Sonegawa H., Du G., Yong R., Takaishi M., SakaguchiM., Huh N.H. Isolation of a bone marrow-derived stem cell line with highproliferation; potential and its application for preventing acute fatal liver failure// Stem Cells.-2007.-25.-2855-63.103107. Mohamadnejad M., Alimoghaddam K., Mohyeddin-BonabM., Bagheri M., Bashtar M., Ghanaati H., Baharvand H., GhavamzadehA., Malekzadeh R. Phase 1 trial of autologous bone marrow mesenchymalstem cell transplantation in patients with decompensated liver cirrhosis //Arch Iran Med. - 2007. - 10(4).
- 459-66.108. Mohamadnejad M., Namiri M., Bagheri M., Hashemi S.M.,Ghanaati H., Zare Mehrjardi N., Kazemi Ashtiani S., Malekzadeh R.,Baharvand H. Phase 1 human trial of autologous bone marrowhematopoietic stem cell transplantation in patients with decompensatedcirrhosis // World J Gastroenterol. - 2007. - 28. -13(24). - 3359-63.109. Mohamed B.A., Sami C., Mohamed B.K., Abdeljabar H., AliB.A., Noomen M., Ahmed N.G., Mohamed H.M., Hatem J., Mohamed E.,Habib J., Awatef B.A., Slim H., Ali A.
Liver regeneration after majorhepatectomy. Evaluation of dogs hepatectomy // Tunis Med.-2005.-83.556.110. Moharib M.N., Waldemar O.L., Mikhail N.E., Nossier M.M.,Atta S.A., Saber M.A. Allogenic hepatocyte transplantation inimmunomodulated Lewis rats with acute liver insufficiency followinghepatectomy // J Egypt Soc Parasitol.-2014.-44.-221-8.111.
Montenegro W.S., Malafaia O., Nassif P.A., Moreira L.B.,Prestes M.A., Kume M.H., Jurkonis L.B., Cella I.F. Evaluation of liverregeneration with use of diet supplemented with l-arginine // ActaCirúrgica Brasileira.-2014.-29(9).-603-8.112. Morinaga A., Ogata T., Kage M., Kinoshita H., Aoyagi S.Comparison of liver regeneration after a splenectomy and splenic arteryligation in a dimethylnitrosamine-induced cirrhotic rat model // HPB(Oxford).-2010.-12(1).-22-30.104113. Nagaki M., Sugiyama A., Naiki T., Ohsawa Y., Moriwaki H.Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cellcycle progression in rat hepatocytes by extracellular matrix // Hepatol. - 2000.
32(3). - 488-96.114. Nagamoto Y., Takayama K., Ohashi K., Okamoto R., Sakurai F.,Tachibana M., Kawabata K., Mizuguchi H. Transplantation of a human iPSCderived hepatocyte sheet increases survival in mice with acute liver failure // JHepatol.-2016 .-64(5).-1068-75.115. Nagata H., Ito M., Shirota C., Edge A., McCowan T.C., Fox I.J.Route of hepatocyte delivery affects hepatocyte engraftment in the spleen //Transplantation.-2003.-76.-732–4.116. Nardo B., Vaccarisi S., Pellegrino V., Cannistrà M., Barcellona E.,Cavallari G.
Extracorporeal portal vein arterialization in man after extendedhepatectomy to prevent acute liver failure: a case report // Transplant Proc. 2011. - 43(4). - 1193-5.117. Nejak-Bowen K., Orr A., Bowen W.C., Michalopoulos G.K.Conditional genetic elimination of hepatocyte growth factor in micecompromises liver regeneration after partial hepatectomy // PLoS One. - 2013. 8(3).118. Newsome P.N., Plevris J.N., Nelson L.J., Hayes P.C. Animalmodels of fulminant hepatic failure: a critical evaluation // Liver Transpl.2000.-6.-21-31.119.
Nishikawa T., Bell A., Brooks J.M., Setoyama K., Melis M., HanB., Fukumitsu K., Handa K., Tian J., H. Kaestner K., Vodovotz Y., Locker J.,Soto-Gutierrez A., Ira J. Fox Resetting the transcription factor network reversesterminal chronic hepatic failure // J Clin Invest.-2015.-125(4).-1533–44.105120. Odorico Y.S., Kanfman D.S., Thomson Y.A. Multilineagedifferentiation from human ESC lines // Stem Cells.-2001.-19.-193-204.121.
Ogawa S., Miyagawa S. Potentials of regenerative medicinefor liver disease // Surg Today.-2009.-39(12).-1019-25.122. Panis Y., McMullan D.M., Emond J.C. Progressive necrosisafter hepatectomy and the pathophysiology of liver failure after massiveresection // Surgery.-1997.-121.-142–9.123. Papagoras D., Papalois A., Tsaroucha A. Beneficial effect ofanantibody againstinterleukin-2receptor(daclizumab)inanexperimental model of hepatocyte xenotransplantation.- World J.Gastroenterol.-2007.-13.-1435-37.124.
Peng L., Xie D.Y., Lin B.L., Liu J., Zhu H.P., Xie C., ZhengY.B., Gao Z.L. Autologous bone marrow mesenchymal stem celltransplantation in liver failure patients caused by hepatitis B: Short-termand long-term outcomes // Hepatology.-2011.-54.820-8.125. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M.,Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S., Goff J.P. Bonemarrow as a potential source of hepatic oval cells // Science.-1999.-14.284.-1168-70.126. Pilat N., Unger L., Berlakovich G.A. Implication for BoneMarrow Derived Stem Cells in Hepatocyte Regeneration after orthotopicLiver Transplantation // Int J Hepatol.-2013.-3106-12. .127. Prasse K.W., Bjorling D.E., Holmes R.A., Cornelius L.M.Indocyanine green and ammonia tolerance in partially hepatectomized andhepatic devascularized, anesthetized dogs // Am J Vet Res.-1983.-44.2320-23.106128.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
